Typical Vs Atypical Hemolytic Uremic Syndrome Direct

The fundamental differences between typical and atypical HUS dictate radically different management strategies. For typical HUS, treatment is supportive. Antibiotics are contraindicated as they may increase Shiga toxin release, and plasma exchange is generally ineffective. The key is to maintain hydration, manage electrolytes, and support renal function until the endothelium heals and the thrombotic process resolves spontaneously.

Clinically, typical HUS presents with a classic prodrome of several days of watery diarrhea followed by bloody diarrhea (dysentery). Approximately five to ten days after the onset of diarrhea, the triad of HUS manifests: pallor (anemia), petechiae and bruising (thrombocytopenia), and decreased urine output (acute kidney injury). The prognosis for typical HUS is surprisingly favorable. With aggressive supportive care—including meticulous fluid and electrolyte management, blood transfusions, and often dialysis—the majority of children recover renal function completely. The mortality rate is low (1-5%) in the acute phase, and long-term sequelae, such as chronic kidney disease or hypertension, occur in a minority of patients. Crucially, typical HUS is not a recurrent disease; once a patient recovers from the acute infection, the syndrome does not return. typical vs atypical hemolytic uremic syndrome

While aHUS can be triggered by an environmental insult (e.g., infection, pregnancy, surgery, certain medications), the fundamental problem is an intrinsic failure to regulate the complement cascade. This leads to systemic, recurrent, and progressive thrombotic microangiopathy, with a predilection for the kidneys but often affecting other organs such as the brain, heart, and gastrointestinal tract. The clinical presentation is variable and can lack the diarrheal prodrome typical of STEC-HUS. The prognosis for aHUS before the modern era was grim, with up to 50% of patients progressing to end-stage renal disease (ESRD) or death within the first year of diagnosis. Furthermore, aHUS is characterized by a high rate of recurrence, especially after kidney transplantation—indeed, the disease frequently destroys the transplanted organ unless the underlying complement dysregulation is addressed. The fundamental differences between typical and atypical HUS

Typical HUS is primarily a disease of childhood, most frequently occurring after an episode of bloody diarrhea caused by specific strains of E. coli , most notably O157:H7. The pathogenesis begins in the gut, where the bacterium releases Shiga toxin. This toxin enters the bloodstream and targets vascular endothelial cells, particularly those in the kidneys and brain. Shiga toxin directly damages these cells, triggering a local inflammatory response and exposing the underlying basement membrane. This leads to platelet adhesion, aggregation, and the formation of microthrombi in the small blood vessels of the renal glomeruli. The key is to maintain hydration, manage electrolytes,